ישראל -
עברית -
Ministry of Health
אקמולי פורטה 250 מג פתילות
teva israel ltd - paracetamol - פתילות - paracetamol 250 mg - paracetamol - paracetamol - relief of pain and fever.
ישראל -
עברית -
Ministry of Health
אקמולי פורטה 250 מג5 מל בטעם תותי-פרוטי
teva pharmaceutical industries ltd, israel - paracetamol - סירופ - paracetamol 250 mg / 5 ml - paracetamol - paracetamol - analgesic, antipyretic.
ישראל -
עברית -
Ministry of Health
אקמולי פורטה 250 מג5 מל סירופ בטעם תות שדה
teva pharmaceutical industries ltd, israel - paracetamol - סירופ - paracetamol 250 mg / 5 ml - paracetamol - paracetamol - analgesic, antipyretic.
ישראל -
עברית -
Ministry of Health
אקמולי 125 מג5 מל סירופ בטעם פטל
teva pharmaceutical industries ltd, israel - paracetamol - סירופ - paracetamol 125 mg / 5 ml - paracetamol - paracetamol - analgesic, antipyretic.
ישראל -
עברית -
Ministry of Health
אקמולי 125 מג5 מל סירופ בטעם פירות
teva pharmaceutical industries ltd, israel - paracetamol - סירופ - paracetamol 125 mg / 5 ml - paracetamol - paracetamol - analgesic, antipyretic.
ישראל -
עברית -
Ministry of Health
אקמולי 125 מג5 מל סירופ בטעם תות שדה
teva israel ltd - paracetamol - סירופ - paracetamol 25 mg/ml ml - paracetamol - paracetamol - analgesic, antipyretic.
ישראל -
עברית -
Ministry of Health
קפרה תמיסה לבליעה
cts ltd - levetiracetam - תמיסה - levetiracetam 100 mg/ml - levetiracetam - levetiracetam - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. keppra is indicated as adjunctive therapy - in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
ישראל -
עברית -
Ministry of Health
לוותרים תמיסה
trima israel pharmaceutical products maabarot ltd - levetiracetam - תמיסה (פומי) - levetiracetam 100 mg/ml - levetiracetam - levetiracetam - levetrim solution is indicated as:- monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. - adjunctive therapy:in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy